Beyond Seizures: Exploring Cannabidiol in Dravet Syndrome
Priscilla Simon1, Nair Shreedharsini Rajagopalan1, Fathima Jahnas1, Farhana Sudheer1, Mohammed Ameen Pattambi1, Sai Keerthana Puthiyedath Cheruvatta1
- 1Department of Pharmacy Practice, Al Shifa College of Pharmacy, Perinthalmanna, Malappuram, Kerala, INDIA.
Received: 04-10-2024; Revised: 16-11-2024; Accepted: 17-12-2024.
Volume 13, Issue 3 · pp. 885–889 · PUBLISHED · DOI: 10.5530/ajbls.2024.13.106
ABSTRACT
Aim: Dravet Syndrome (DS) is a severe epileptic and developmental encephalopathy causing drug-resistant seizures and developmental delay; this report presents two infant cases and evaluates CBD as adjunct therapy. Materials and Methods: Clinical case details, genetic testing (SCN1A) and treatment response were recorded and monitored. Results: Cannabidiol (CBD) added to regimens provided improved seizure control in refractory cases, with noted adverse effects including somnolence and GI upset. Conclusion: CBD may be beneficial for seizure control in DS but requires careful monitoring and further research on pediatric dosing.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Simon, P., Rajagopalan, N. S., Jahnas, F., Sudheer, F., Pattambi, M. A., & Cheruvatta, S. K. P. (). Beyond Seizures: Exploring Cannabidiol in Dravet Syndrome. Asian Journal of Biological and Life sciences, 13(3), 885–889. https://doi.org/10.5530/ajbls.2024.13.106
